• V. PĂDUREANU University of Medicine and Pharmacy of Craiova
  • Maria BOGDAN University of Medicine and Pharmacy of Craiova
  • Mihaela-Simona SUBȚIRELU University of Medicine and Pharmacy of Craiova
  • Rodica PĂDUREANU University of Medicine and Pharmacy of Craiova
  • Adina TURCU-STIOLICA University of Medicine and Pharmacy of Craiova
  • F. PETRESCU University of Medicine and Pharmacy of Craiova
  • Florentina DUMITRESCU University of Medicine and Pharmacy of Craiova
  • Liliana MITITELU-TARȚĂU “Grigore T. Popa” University of Medicine and Pharmacy Iasi


The first case of new coronavirus infection was reported first in the Wuhan city area from China in December 2019. The virus spread rapidly worldwide, produced an atypical cluster of pneumonia, was known all over the world as Coronavirus Disease 2019 (COVID-19) and, in Romania, first case was registered on the 26th of February. In Romania, the number of cases increased constantly, and a lot of healthcare professionals were infected with SARS-CoV-2. Aim: The aim of our study was to assess the opinion of healthcare professionals on the situation generated by the COVID-19 pandemic and to find what treatment against COVID-19 (a future vaccine, hydroxychloroquine) would be accepted by healthcare professionals. Material and methods: We used an online survey that was conducted from April 15th, 2020 to May 15th, 2020. The survey was developed using Google Forms and included 15 items. The respondents were recruited from health professionals (physicians, pharmacists and nurses), and future health professionals. Results: a number of 529 healthcare professionals were included in the study from different cities of the country. A total of 365 respondents (69%) agreed with the COVID-19 vaccine. Differences in accepting the vaccination against COVID-19 coverage by profession (p=0.011<0.05) were found. Conclusions: Based on the assessment of the current COVID-19 situation globally, the COVID-19 vaccines must be inoculated to the healthcare workers, but training on vaccination and compulsory measures may be needed in order to achieve better coverage.

Author Biographies

V. PĂDUREANU, University of Medicine and Pharmacy of Craiova

Faculty of Medicine
Department of Internal Medicine

Maria BOGDAN, University of Medicine and Pharmacy of Craiova

Faculty of Medicine
Department of Pharmacology

Mihaela-Simona SUBȚIRELU, University of Medicine and Pharmacy of Craiova

Faculty of Medicine
Department of Pharmacoeconomics

Rodica PĂDUREANU, University of Medicine and Pharmacy of Craiova

Faculty of Medicine
Department of Biochemistry

Adina TURCU-STIOLICA, University of Medicine and Pharmacy of Craiova

Faculty of Medicine
Department of Pharmacoeconomics

F. PETRESCU, University of Medicine and Pharmacy of Craiova

Faculty of Medicine
Department of Internal Medicine

Florentina DUMITRESCU, University of Medicine and Pharmacy of Craiova

Faculty of Medicine
Department of Infectious Diseases

Liliana MITITELU-TARȚĂU, “Grigore T. Popa” University of Medicine and Pharmacy Iasi

Faculty of Medicine
Department of Morpho-functional Sciences (II)


1. Rodriguez-Morales AJ, Cardona-Ospina JA, Gutiérrez-Ocampo E, et al. Latin American Network of Coronavirus Disease 2019-COVID-19 Research (LANCOVID-19). Clinical, laboratory and imaging features of COVID-19: A systematic review and meta-analysis. Travel Med Infect Dis 2020; 101623.
2. ***World Health Organization (WHO).
3. Lai CC, Shih TP, Ko WC, Tang HJ, Hsueh PR. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): The epidemic and the challenges. Int J Antimicrob Agents 2020; 55: 105924.
4. Lake MA. What we know so far: COVID19 current clinical knowledge and research. Clin. Med 2020; 20: 124-127.
5. Gherghel I, Bulai M. Is Romania ready to face the novel coronavirus (COVID-19) outbreak ? The role of incoming travelers and that of Romanian diaspora. Trav Med Infect Dis 2020; 34: 101628.
6. Islam MT, Nasiruddin M, Khan IN, Mishra SK, Kudrat-E-Zahan M, Riaz TA, et al. A Perspective on Emerging Therapeutic Interventions for COVID-19. Front Public. Health 2020; 8: 281.
7. Lee, Sun Hee, et al. Can post-exposure prophylaxis for COVID-19 be considered as one of outbreak response strategies in long-term care hospitals? Int J Antimicrob Agents 2020; 55(6): 105988.
8. Garcia-Cremades M. Optimizing hydroxychloroquine dosing for patients with COVID-19: An inte-grative modeling approach for effective drug repurposing. Clinical pharmacology and therapeutics 2020; 108(2): 253-263.
9. Fantini J, Di Scala C, Chahinian H, Yahi N. Structural and molecular modeling studies reveal a new mechanism of action of chloroquine and hydroxychloroquine against SARS-CoV-2 infection. Int J Antimicrob Agents 2020; 55(5): 105960.
10. Gautret P, et al. Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open label non-randomized clinical trial. Int J Antimicrob Agents 2020; 56(1): 105949.
11. Yao X, et al. In Vitro Antiviral Activity and Projection of Optimized Dosing Design of Hydroxychlo-roquine for the Treatment of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2). Clin Inf Dis 2020; 71(15): 732-739.
12. Zhou T, Liu Q, Yang Z, Liao J, et al. Preliminary prediction of the basic reproduction number of the Wuhan novel coronavirus 2019-nCoV. J Evid Based Med 2020; 13(1): 3-7.
13. Hoang C. Nguyen, Minh H. Nguyen, Binh N. Do, et al. People with Suspected COVID-19 Symptoms Were More Likely Depressed and Had Lower Health-Related Quality of Life: The Potential Benefit of Health Literacy. J Clin Med 2020; 9: 965.
14. Bao Y, Sun Y, Meng S, Shi J, Lu L. 2019-nCoV epidemic: Address mental health care to empower society. Lancet 2020; 395(10224): e37-e38.
15. Xu Z, Li S, Tian S, Li H, Kong L.-Q. Full spectrum of COVID-19 severity still being depicted. Lancet 2020; 395(10228): 947-948.
16. Shimizu K. 2019-nCoV, fake news, and racism. Lancet 2020; 395(10225): 685-686.
17. Brooks SK, Webster RK, Smith LE, et al. The psychological impact of quarantine and how to reduce it: Rapid review of the evidence. Lancet 2020; 395(10227): 912-920.
18. ***Editorial Lancet. The health illiteracy problem in the USA. Lancet 2009; 374(9707): 2028.
19. Sørensen K, Van den Broucke S, Brand H, Fullam J, Doyle G,Pelikan J, Slonszka Z. Health literacy and public health: A systematic review and integration of definitions and models. BMC Public Health 2012; 12: 80.
20. del Carmen Pérez-Fuentes M, del Mar Molero Jurado M, Oropesa Ruiz NF, África Martos Martínez AM, del Mar Simón Márquez M, Herrera-Peco I, Gázquez Linares JJ. Questionnaire on Perception of Threat from COVID-19. J Clin Med 2020; 9(4): 1196.
21. Hernández BC, Rugarcía YT. Attitudes toward the risk prevention in health professionals in cases of epidemiological alert. Med Segur Trab 2015; 61: 254-272.
22. Lai J, Ma S, Wang Y, Cai Z, et al. Factors Associated With Mental Health Outcomes Among Health Care Workers Exposed to Coronavirus Disease 2019. JAMA Netw Open 2020; 3: e203976.
23. Ho CS, Chee, CY, Ho RC. Mental Health strategies to combat the psychological impact of COVID-19 beyond paranoia and panic. Ann Acad Med Singap 2020; 49: 1-3.
24. Broadbent E, Wilkes C, Koschwanez H, Weinman J, Norton S, Petrie KJ. A systematic review and meta-analysis of the Brief Illness Perception Questionnaire. Psychol Health 2015; 30: 1361-1385.
25. Turcu-Stiolica A, Taerel AE, Turcu-Stiolica R, Identifying and measuring compliance and adherence in antidepressants taking, Emerging Markets Queries in Finance and Business. Procedia Economics and Finance 2014; 15: 836-839.
26. Conte C, Sogni F, Affanni P, Veronesi L, Argentiero A, Esposito S. Vaccines against Coronaviruses: The State of the Art. Vaccines 2020; 8: 309.
27. Pappa S, Ntella V, Giannakas T, Giannakoulis V, Papoutsi E, Katsaounou P. Prevalence of depression, anxiety, and insomnia among healthcare workers during the COVID-19 pandemic: A systematic review and meta-analysis. Brain Behavior Immun 2020; 88: 901-907.
28. Taerel AE, Stancu E, Turcu-Stiolica A. Pharmaceutical assistance for the elderly. Modern Research in Health, Education and Social Sciences: Conference proceedings 2014; 163-167.
29. Mic O, Turcu-Stiolica A. The outcomes of a pharmaceutical care assistance program in a Romanian community pharmacy. Value in Health 2016; 19(7): A868.
30. Boboia A, Polinicencu C. Application of the Pareto analysis regarding the research on the value of preparations in community pharmacies from Cluj-Napoca, Romania. Farmacia 2012; 60(4): 578-585.
31. Boboia A, Oros GC, Polinicencu C, Mirel S. Researches concerning the profitability of the community pharmacy within the context of world economic and financial crisis. Farmacia 2014; 62(5): 1025-1036.
32. ***International Pharmaceutical Federation. Coronavirus / COVID-19 preparedness. Available on: Accessed 15 June 2020.
33. Bukhari N, Rasheed H, Nayye B, et al. Pharmacists at the frontline beating the COVID-19 pandemic. J of Pharm Policy and Pract 2020; 13: 8.
34. Sanders J, Monogue M, Jodlowski T, et al. Pharmacologic treatments for coronavirus disease 2019: A review. JAMA 2020. doi:10.1001/jama.2020.6019.
35. Meyerowitz EA, Vannier AGL, Friesen MGN, et al. Rethinking the role of hydroxychloroquine in the treatment of COVID-19. The FASEB Journal 2020; 34(5): 6027-6037.
36. Mehra MR, Desai SS, Ruschitzka F, et al. Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: a multinational registry analysis. Lancet 2020 doi: 10.1016/So140-6736(20)31174-0.